Home / Health / Pakistan's Syringe Crisis: A Man-Made Epidemic?
Pakistan's Syringe Crisis: A Man-Made Epidemic?
2 May
Summary
- Pakistan Medical Association warns of a man-made epidemic due to reusable syringes.
- Ban on disposable syringes has become a 'paper-only' policy since 2021.
- 350,000 to 369,000 people are estimated to be living with HIV in Pakistan.

The Pakistan Medical Association (PMA) has raised serious concerns over the prevalent manufacturing and use of reusable syringes, a practice that contravenes a nationwide ban. The association warns that this situation is escalating towards a "man-made epidemic," directly endangering millions of lives. The PMA has called for a comprehensive audit of all syringe manufacturing facilities and the immediate seizure of any non-compliant, falsely labelled stocks that have entered the supply chain.
The ban on conventional disposable syringes, initiated in 2021 and once lauded for infection control, is now criticized as a "paper-only" policy. The PMA holds the Drug Regulatory Authority of Pakistan (Drap) and provincial health authorities accountable for this "catastrophic failure." The association highlights that an estimated 350,000 to 369,000 people are currently living with HIV in Pakistan. In the first quarter of 2026 alone, 894 new HIV cases were recorded in Sindh, impacting 329 children. Furthermore, new HIV infections among children aged 0-14 have surged from 530 in 2010 to over 1,800 annually, with more than 1,100 child deaths from AIDS-related complications in 2023.
The PMA is urging the government to launch an emergency public awareness campaign to help citizens identify genuine auto-disable syringes. They are also demanding stringent legal action against healthcare providers found using or possessing banned conventional syringes. Without immediate intervention, the PMA predicts that HIV cases could rise dramatically, potentially leading to an uncontrollable national health emergency and exacerbating Pakistan's existing burden of Hepatitis C, which is the second-highest globally. Projections suggest the number of Hepatitis C cases could reach 12.6 million by 2030 if corrective measures are not implemented.